These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 3210320)
21. Idiopathic cardiomyopathies. A review of pathologic studies and mechanisms of pathogenesis. Gravanis MB; Ansari AA Arch Pathol Lab Med; 1987 Oct; 111(10):915-29. PubMed ID: 3632267 [TBL] [Abstract][Full Text] [Related]
22. Characteristic distribution of circulating autoantibodies against G-protein coupled cardiovascular receptors in patients with idiopathic dilated and hypertrophic cardiomyopathy. Matsui S; Fu M Int J Cardiol; 1996 May; 54(2):143-7. PubMed ID: 8803678 [TBL] [Abstract][Full Text] [Related]
23. [Hypertrophic cardiomyopathy and dilated cardiomyopathy in six members of a family]. Tatsumi T; Sirayama T; Tatsukawa H; Kosugi Y; Okada T; Azuma A; Omori I; Inoue N; Shimoo K; Nakagawa T Kokyu To Junkan; 1988 Sep; 36(9):1023-8. PubMed ID: 3238180 [No Abstract] [Full Text] [Related]
25. [Incidence of ventricular arrhythmias and their correlation with sudden death in patients with idiopathic dilated myocardiopathy]. Illanes G; González R; Corbalán R; Arriagada D; Fajuri A; Valenzuela P Rev Med Chil; 1984 Sep; 112(9):877-83. PubMed ID: 6543474 [No Abstract] [Full Text] [Related]
26. [Value of T-lymphocyte subpopulations in dilated myocardiopathy]. Pallarés C; Blanchs L; Gausí C; Buendía E Med Clin (Barc); 1985 Mar; 84(8):336-7. PubMed ID: 3872390 [No Abstract] [Full Text] [Related]
27. Lack of T cell response to cardiac myosin and a reduced response to PPD in patients with idiopathic dilated cardiomyopathy. Bromelow KV; Souberbielle B; Alavi A; Goldman JH; Libera LD; Dalgleish AG; McKenna WJ J Autoimmun; 1997 Apr; 10(2):219-27. PubMed ID: 9185883 [TBL] [Abstract][Full Text] [Related]
28. [Patients with cardiomyopathy screened by an annual health check]. Katada M; Noda A; Suzuki M; Hidaka T; Kawazoe N; Sobue T; Yokota M; Ogura Y; Yasui S Rinsho Byori; 1999 Apr; 47(4):365-9. PubMed ID: 10340011 [TBL] [Abstract][Full Text] [Related]
29. [Significance of HLA analysis and penetrance of ASH in familial cardiomyopathy with coexisting hypertrophic and dilated-like types in two families]. Kishimoto C; Tomioka N; Kawai C; Tamaki S; Kadota K; Maruya E; Saji H Kokyu To Junkan; 1986 Sep; 34(9):959-64. PubMed ID: 3786961 [No Abstract] [Full Text] [Related]
30. [Mechanocardiography findings and hypertrophic and dilated cardiomyopathy]. Assmann I; Dittrich P Z Gesamte Inn Med; 1987 Mar; 42(6):155-60. PubMed ID: 3604345 [TBL] [Abstract][Full Text] [Related]
31. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945 [TBL] [Abstract][Full Text] [Related]
32. T-lymphocyte subsets in patients with idiopathic dilated cardiomyopathy. Huber KC; Gersh BJ; Sugrue DD; Frye RL; Bailey KR; Ritts RE Int J Cardiol; 1989 Jan; 22(1):59-66. PubMed ID: 2564379 [TBL] [Abstract][Full Text] [Related]
33. [T-lymphocyte subgroup and the nature killer cell activity in cardiovascular diseases]. Xie X; Dai T Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):535-6. PubMed ID: 10073000 [No Abstract] [Full Text] [Related]
34. Immunogenetic risk factors of dilated cardiomyopathy. Popovici M; Groppa L; Kalinina L Blood Press Suppl; 1996; 3():49-52. PubMed ID: 8973770 [TBL] [Abstract][Full Text] [Related]
35. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods. Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331 [TBL] [Abstract][Full Text] [Related]
36. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984 [TBL] [Abstract][Full Text] [Related]
37. No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy. Thude H; Gerlach K; Richartz B; Krack A; Brenke B; Pethig K; Figulla HR; Barz D Hum Immunol; 2005 Sep; 66(9):1008-12. PubMed ID: 16360841 [TBL] [Abstract][Full Text] [Related]
39. Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy. Högye M; Mándi Y; Csanády M; Sepp R; Buzás K Am J Cardiol; 2004 Jul; 94(2):249-51. PubMed ID: 15246916 [TBL] [Abstract][Full Text] [Related]
40. [Occurrence of HLA-antigens in patients with hypertrophic cardiomyopathy]. Bodem R; Zipperle S; Ho A; Lenhard V Z Kardiol; 1982 Dec; 71(12):820-3. PubMed ID: 6962579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]